The ACME Laboratories Ltd.

DSE:ACMELAB Stock Report

Market Cap: ৳16.8b

ACME Laboratories Past Earnings Performance

Past criteria checks 3/6

ACME Laboratories has been growing earnings at an average annual rate of 12.9%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 12.9% per year. ACME Laboratories's return on equity is 9.2%, and it has net margins of 7.3%.

Key information

12.9%

Earnings growth rate

12.9%

EPS growth rate

Pharmaceuticals Industry Growth11.0%
Revenue growth rate12.9%
Return on equity9.2%
Net Margin7.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How ACME Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DSE:ACMELAB Revenue, expenses and earnings (BDT Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2432,3522,3507,7790
30 Jun 2431,9322,4567,5390
31 Mar 2430,8112,4207,1870
31 Dec 2329,3942,3746,9290
30 Sep 2328,2802,3426,7040
30 Jun 2326,9482,3046,4240
31 Mar 2325,8692,2026,0050
31 Dec 2225,3342,1695,7480
30 Sep 2224,5062,1445,5740
30 Jun 2223,8582,1115,3810
31 Mar 2223,2031,9855,1170
31 Dec 2122,3861,8724,8550
30 Sep 2121,7351,7424,6700
30 Jun 2120,7701,5694,4570
31 Mar 2120,3411,5034,1460
31 Dec 2019,8751,4673,9500
30 Sep 2019,5161,4653,7710
30 Jun 2019,0041,4503,5510
31 Mar 2018,1611,4213,6120
31 Dec 1917,4651,4353,3620
30 Sep 1916,8591,4523,1200
30 Jun 1916,3091,4403,0180
31 Mar 1915,9551,3773,0140
31 Dec 1815,5421,4002,9350
30 Sep 1815,1551,3942,9230
30 Jun 1814,8141,4272,8430
31 Mar 1814,7081,4492,7890
31 Dec 1714,3351,4432,6750
30 Sep 1713,9431,4402,5620
30 Jun 1713,5761,3982,5220
31 Mar 1713,3581,5232,5090
31 Dec 1613,2701,3892,4540
30 Sep 1612,9671,2502,3850
30 Jun 1612,6451,1012,3050
31 Mar 1612,3969902,0720
30 Jun 1511,4969221,9990
30 Jun 1410,2188942,0880

Quality Earnings: ACMELAB has high quality earnings.

Growing Profit Margin: ACMELAB's current net profit margins (7.3%) are lower than last year (8.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: ACMELAB's earnings have grown by 12.9% per year over the past 5 years.

Accelerating Growth: ACMELAB's earnings growth over the past year (0.3%) is below its 5-year average (12.9% per year).

Earnings vs Industry: ACMELAB earnings growth over the past year (0.3%) exceeded the Pharmaceuticals industry -5.5%.

Return on Equity

High ROE: ACMELAB's Return on Equity (9.2%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 10:30
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

The ACME Laboratories Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution